SEC Form 4 · accession 0001127602-16-058849

Alkermes plc. · ALKS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — EVP, R&D & CMO, Alkermes, Inc.

Period of report

Jul 26, 2016

Accepted (ET)

Jul 28, 2016 · 5:06 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001520262

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Ordinary Shares	Jul 26, 2016	M	800	$16.55	A	46,111	D
Ordinary Shares^F3	Jul 26, 2016	S	800	$51.8191	D	45,311	D
Ordinary Shares	Jul 27, 2016	M	34,399	$16.55	A	79,710	D
Ordinary Shares^F4	Jul 27, 2016	S	34,399	$51.9514	D	45,311	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (Right to Buy)^F5	$16.55	Jul 26, 2016	M	800	D	—	May 21, 2022	Ordinary Shares	800	94,200	D
Employee Stock Option (Right to Buy)^F5	$16.55	Jul 27, 2016	M	34,399	D	—	May 21, 2022	Ordinary Shares	34,399	59,801	D

F1This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $51.81 to $51.85. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F4The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $51.80 to $52.25. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F5These options are fully vested in accordance with their terms.